Insider Transactions in Q4 2020 at Encompass Health Corp (EHC)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2020
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
81,031
+50.0%
|
-
|
|
Nov 18
2020
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
81,031
-51.52%
|
-
|
|
Nov 17
2020
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,650
-24.85%
|
$498,750
$75.22 P/Share
|
|
Oct 16
2020
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.42%
|
-
|
|
Oct 16
2020
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
943
+0.39%
|
$32,062
$34.21 P/Share
|
|
Oct 16
2020
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.4%
|
-
|
|
Oct 16
2020
|
Yvonne M Curl Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.4%
|
-
|
|
Oct 16
2020
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.37%
|
-
|
|
Oct 16
2020
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
117
+0.4%
|
-
|
|
Oct 16
2020
|
Leo I Higdon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.39%
|
-
|
|
Oct 16
2020
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
117
+0.4%
|
-
|
|
Oct 16
2020
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.42%
|
-
|
|
Oct 16
2020
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
307
+0.2%
|
$9,517
$31.75 P/Share
|
|
Oct 16
2020
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
34
+0.42%
|
-
|
|
Oct 16
2020
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
360
+0.19%
|
$12,240
$34.2 P/Share
|
|
Oct 16
2020
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.42%
|
-
|